Your session is about to expire
← Back to Search
Other
Energy Drink for Enhancing Cognition and Metabolism (ASH Trial)
N/A
Recruiting
Led By Chad M Kerksick, PhD
Research Sponsored by Lindenwood University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Male or female participants between 18 - 50 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights
ASH Trial Summary
This trial studies the effects of caffeine energy drinks on energy, focus, reaction time, and fat & carb oxidation in 60 adults. Double-blind, 28 day trial to compare effects of caffeine vs placebo.
Who is the study for?
Healthy adults aged 18-50, with a BMI of >24 to <31.9, who are moderately active and consume around 300 mg of caffeine daily can join this study. They shouldn't be treated for serious diseases or disorders, pregnant, using certain medications, or have a history of substance abuse or major psychiatric conditions.Check my eligibility
What is being tested?
This trial is testing whether a caffeine-based energy drink affects energy expenditure, fat burning, reaction time and focus compared to a placebo. Participants will be randomly assigned the drink or placebo in a double-blind setup and tested before and after 28 days.See study design
What are the potential side effects?
Potential side effects may include increased heart rate, jitteriness, trouble sleeping, digestive discomforts like nausea or upset stomach due to the caffeine content in the energy drink.
ASH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 50 years old.
ASH Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 28 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Energy expenditure (kcals/min)
Secondary outcome measures
Choice reaction time
Concentration Visual Analog Scale
Energy Visual Analog Scale
+5 moreOther outcome measures
Blood Pressure
Heart Rate
Self-reported adverse events
ASH Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Caffeine-Based Energy DrinkActive Control1 Intervention
Caffeine-based energy drink containing 200 mg caffeine
Group II: PlaceboPlacebo Group1 Intervention
Placebo (void of all actives)
Find a Location
Who is running the clinical trial?
Lindenwood UniversityLead Sponsor
18 Previous Clinical Trials
706 Total Patients Enrolled
1 Trials studying Reaction Time
15 Patients Enrolled for Reaction Time
Chad M Kerksick, PhDPrincipal InvestigatorLindenwood University
7 Previous Clinical Trials
308 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You smoke more than 10 cigarettes per day.I am willing and able to follow the study's requirements and procedures.I have or am being treated for heart, brain, immune, thyroid, kidney, liver diseases or other serious health conditions.I am between 18 and 50 years old.I am healthy and not currently treated for serious health issues.I have not had any cancer, except for skin cancer without spread or cervical cancer that hasn't spread, in the last 5 years.I am currently taking medication for high cholesterol or high blood pressure.I do not have issues swallowing or digesting food due to a GI tract problem.You regularly engage in physical exercise, such as aerobic or strength training, at least 2 to 5 times per week.I was hospitalized for a mental health issue in the last year.You have had problems with alcohol or drugs within the past 6 months.I have been diagnosed with diabetes.You regularly consume a moderate amount of caffeine, which is about the same as drinking three cups of coffee per day.
Research Study Groups:
This trial has the following groups:- Group 1: Placebo
- Group 2: Caffeine-Based Energy Drink
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
To what sort of persons is enrollment in this investigation open?
"To be eligible for inclusion in this clinical trial, prospective participants must expend energy within the age range of 18-50. Currently, a total of 60 individuals are being recruited."
Answered by AI
Is the age restriction to participate in this research limited to those under 80 years?
"This trial is seeking out participants aged 18 to 50. In contrast, there are 5 trials specifically for children and 27 studies that favor elderly patients over 65 years old."
Answered by AI
Are there currently any available vacancies for prospective participants in this research?
"Evidently, the clinical trial listed on clinicialtrials.gov is not presently seeking patients; it was posted on September 1st 2023 and edited for the last time on August 10th 2023. Conversely, there are 38 other trials currently enrolling volunteers at this current juncture."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger